Healthcare provider profile · identity verified

Scott F Brown, MD

Family Practice · MILLERSBURG, OH · NPI 1174525919

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	620	186
Lisinopril	Lisinopril	562	158
Omeprazole	Omeprazole	331	80
Amlodipine Besylate	Amlodipine Besylate	299	85
Hydrochlorothiazide	Hydrochlorothiazide	295	86
Metformin Hcl	Metformin Hcl	247	64
Levothyroxine Sodium	Levothyroxine Sodium	243	62
Losartan Potassium	Losartan Potassium	175	55
Furosemide	Furosemide	141	44
Tamsulosin Hcl	Tamsulosin Hcl	133	39
Gabapentin	Gabapentin	126	29
Metoprolol Succinate	Metoprolol Succinate	125	35
Pantoprazole Sodium	Pantoprazole Sodium	117	30
Rosuvastatin Calcium	Rosuvastatin Calcium	112	31
Metoprolol Tartrate	Metoprolol Tartrate	107	35
Albuterol Sulfate Hfa	Albuterol Sulfate	101	20
Pioglitazone Hcl	Pioglitazone Hcl	93	28
Meloxicam	Meloxicam	88	24
Atenolol	Atenolol	86	24
Potassium Chloride	Potassium Chloride	86	26
Warfarin Sodium	Warfarin Sodium	83	19
Allopurinol	Allopurinol	81	23
Clopidogrel	Clopidogrel Bisulfate	78	22
Glimepiride	Glimepiride	78	19
Prednisone	Prednisone	77	37
Spironolactone	Spironolactone	76	14
Trazodone Hcl	Trazodone Hcl	75	20
Sertraline Hcl	Sertraline Hcl	74	24
Tramadol Hcl	Tramadol Hcl	74	20
Celecoxib	Celecoxib	71	17
Lorazepam	Lorazepam	71	18
Venlafaxine Hcl Er	Venlafaxine Hcl	70	suppressed
Alprazolam	Alprazolam	68	19
Famotidine	Famotidine	68	18
Paroxetine Hcl	Paroxetine Hcl	68	19
Zolpidem Tartrate	Zolpidem Tartrate	68	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	22
Fenofibrate	Fenofibrate	64	22
Carvedilol	Carvedilol	61	15
Fluticasone Propionate	Fluticasone Propionate	55	19
Cephalexin	Cephalexin	54	48
Citalopram Hbr	Citalopram Hydrobromide	50	suppressed
Enalapril Maleate	Enalapril Maleate	49	11
Eliquis	Apixaban	47	13
Duloxetine Hcl	Duloxetine Hcl	46	suppressed
Finasteride	Finasteride	46	11
Glipizide	Glipizide	46	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Metformin Hcl Er	Metformin Hcl	45	17
Escitalopram Oxalate	Escitalopram Oxalate	44	14
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Synthroid	Levothyroxine Sodium	43	11
Trulicity	Dulaglutide	40	suppressed
Azithromycin	Azithromycin	39	38
Fluconazole	Fluconazole	39	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	29
Triamcinolone Acetonide	Triamcinolone Acetonide	38	19
Xarelto	Rivaroxaban	37	suppressed
Montelukast Sodium	Montelukast Sodium	36	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Amoxicillin	Amoxicillin	29	22
Labetalol Hcl	Labetalol Hcl	29	suppressed
Lovastatin	Lovastatin	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	25
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	21
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Estradiol	Estradiol	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Carbamazepine	Carbamazepine	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	13
Clonazepam	Clonazepam	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Nystatin	Nystatin	17	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	17	suppressed
Cefdinir	Cefdinir	16	11
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	11
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Felodipine Er	Felodipine	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Clonidine	Clonidine	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Naproxen	Naproxen	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Ozempic	Semaglutide	12	suppressed
Pravastatin Sodium	Pravastatin Sodium	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error